Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone treatment outcomes for pubertal delay in Duchenne muscular dystrophy
2015-003195-68Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Oct 2015
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Sustanon 250 in delayed puberty and Duchenne muscular dystrophy (DMD), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Treatment Satisfaction Questionnaire for Medication total and subscale scores. Started Oct 2015; status: completed.
02
Drugs
Sustanon 250
03
Conditions
delayed pubertyDuchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2015-003195-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003195-68.